Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,321,164
+$3,285,222 QoQ
Shares Held
290,401
+137.2% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 294 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$771,684
PutShares
32,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. BHVN ranks #35 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in BHVN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,321,164 | 290,401 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,035,942 | 122,452 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,383,938 | 122,581 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,094,974 | 139,572 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,088,715 | 148,031 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $2,798,206 | 116,398 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $771,684 | 32,100 | Put | Defined | 2025-11-21 | |
| 2024-12-31 | $214,088 | 5,732 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,416,244 | 108,390 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $535,364 | 15,424 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $465,463 | 8,511 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $1,190,394 | 27,813 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $429,396 | 16,509 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $297,109 | 12,421 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $126,134 | 9,234 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $214,859 | 15,480 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $153,110 | 24,862 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||